Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-26

Clinical Trial Update: Safety and Efficacy Study on AFA-281 for the Treatment of Low Back Pain [Phase 2]

View source ↗

Summary

Clinical trial update indicates a Phase 2 study of AFA-281 for lumbosacral radiculopathy/low back pain is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AFA-281 (AFA-281)

Snippet

Sponsor: Afasci Inc | Conditions: Lumbosacral Radiculopathy | Phase 2 | Status: NOT_YET_RECRUITING